Published since 1985, AIDS Weekly brings you comprehensive coverage of the essential AIDS information you need. Get 30 pages each week - a large news section, intensified coverage of international developments, research updates presented at leading conferences, and journal summaries from the world's medical, social, and health periodicals.

Single user price: $1,629.00 (1 year), $2,695.00 (2 years), $3,595.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,629.00 Two years $2,695.00 Three years $3,595.00

Reports on breakthroughs for human disease involving angiogenesis and anti-angiogenesis continue to dominate the headlines. How do professionals keep up with accurate details of the early clinical trial results? Angiogenesis Weekly's staff provides original conference coverage of breaking news so professionals from the pharmaceutical, health, and research industries are always informed. Understanding and controlling angiogenesis is explored each week in this one complete source of information. Insiders say angiogenesis is among the top five topics of discussion among industry professionals, and Angiogenesis Weekly is the best way to stay up-to-date.

Single user price: $1,629.00 (1 year), $2,695.00 (2 years), $3,595.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,629.00 Two years $2,695.00 Three years $3,595.00

Essential to all key biotech personnel and pharmaceutical professionals, Biotech Week covers news highlights pulled from all NewsRx ( formerly CW Henderson) newsweeklies and includes cross-reference information for further investigation. Editorial insights from our experienced staff give this newsletter a unique perspective into the world of health and pharmaceuticals. Articles are subheaded by pharmaceutical/biotech company names.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Reports the top discoveries, developments, and policies concerning blood and blood products today. Each issue brings you original reporting, the latest-breaking news, research findings, periodical reviews, and a calendar of upcoming meetings. Topics include blood banking, blood products and substitues, bone marrow transplantation, tissue banking, and especially challenges caused by new and emerging infectious agents, and how viral inactivation and other technologies aim to make the blood supply safe.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Published since 1988, this leading cancer resource has expanded to include 30 pages per issue. Each issue is packed with news on research your colleagues are conducting around the world- including cancer vaccines, gene therapies, and biotechnological innovations. You'll get a wide range of research reports on the latest developments as well as journal summaries selected to help you get fresh ideas and further your own work in cancer. Also includes a comprehensive events calendar of upcoming meetings.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Essential to all key pharmaceutical professionals, this publication covers pharmaceutical highlights from across the industry. You'll be the first to know about the latest front line drug developments and therapies including clinical trials, global partnerships and programs, industry news, research findings, conference proceedings, and much more.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

This international weekly features up-to-the-minute reporting on recent discoveries and innovations in human genetic research. Coverage includes advances in genetically engineered vaccines, gene therapy, and pharmaceuticals. Fascinating and timely reading for researchers, clinicians, journalists, and investors.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

The DNA revolution isn't coming...it's here! Genomic manipulations have taken center stage in contemporary biomedical science. Gene therapies already have entered human clinical trials. New insights into the transcriptional regulation of clinically relevant genes provide exciting new pathways for drug development and cancer research. Researchers are racing to unlock the mysteries of human genes, and the impact of new discoveries on the pharmaceutical and health industries is unlimited. Genomics & Genetics Weekly is an invaluable tool for keeping abreast of the staggering amount of research coming from the Human Genome Project and others studying this exciting field.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Essential to all key medical personnel and health professionals, this publication covers health and medicine news from across the industry. This expansive title allows you to learn first hand about the latest developments including clinical trials, pharmaceutical news, global partnerships and programs, research findings, conference proceedings, and much more.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

The human heart is built for amazing endurance - billions of beats in an average lifetime - but is vulnerable to breakdowns. In the U.S. alone, two out of every five people die of heart disease. Some risks, such as lifestyle and diet, are preventable; others are due to genetics, infections, and other uncontrollable factors. Heart Disease Weekly examines the latest potential causes and treatments from a global spectrum and is compiled in one complete source of information. Each issue brings you original reporting, the latest-breaking news, research findings, and a calendar of upcoming events. Topics include gene therapy, myocardial infarction, arrhythnmias, angiogenesis, stroke, cardiac transplantation, industry news, and much more. A must for professionals in the pharmaceutical, biotech, health and research industries.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

With the world's population being threatened by the spread of hepatitis viruses, it's important to stay informed on the latest developments. Hepatitis Weekly focuses on hepatitis A,B,C,D,E, and G, while including such topics as vaccines, transmission, incidence, infection control, therapies, and much more. This incisive newsweekly provides you with quick, encapsulated reports of the latest research and issues, periodical reviews, and conference information- on a worldwide scale.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Emphasizing biological agents and biotechnology, this newsletter provides insight into the immunologic bases of diseases and immune system dysfunctions. Stay current on the latest world news, conference news, as well as journal news. Topics include vaccines, gene therapy, immunoconjugates, cancer biotechnology, monoclonal antibodies, cytokines, immunomodulators, and much more.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Independent Newsweekly Covering the Leading U.S. Health Agencies. Concentrates on the accomplishments and contributions of the U.S. Centers for Disease Control & Prevention and the U.S. Food & Drug Administration. This publication reports first-hand on the CDC's front line involvement with epidemics and threats to public health and the the FDA's latest drug and biological developments in one easy, quick read format. You'll be the first to read about discoveries, clinical trials, legislation, regulation and policies, global partnerships, health care trends, educational progress, and much more. .

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Obesity is the most common chronic disease in the Western world and is reaching epidemic proportions. There are exciting medical and pharmaceutical advances on the horizon. Obesity, Fitness & Wellness Week keeps you up-to-date on the latest breaking international news, conference news, journal news, and upcoming conferences.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

No medical topic is more important - more misunderstood - than pain. Clinicians, administrators, and researchers struggle not only with the difficult medical issues involved but also with often contradictory legal and regulatory demands. Efforts are underway to better manage pain, and to also provide better objective measurements. Every field of medical science is involved with at least some aspect of pain. NewsRx (formerly CW Henderson Publisher) brings you Pain & Central Nervous System Week, a single source that keeps you informed on these issues.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Professionals worldwide consider TB & Outbreaks Week the number one source in the fight against infectious airborne diseases. Subscribers benefit from fast-breaking world news, conference news, journal reviews, and a calendar of upcoming meetings. Topics include pneumonia, Legionnaire's disease, hepatitis, influenza, airborne plagues, vaccine develpment, government involvement, and mycobacteria and tuberculosis-related news.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Vaccines are increasingly viewed as the most viable solution to everything from AIDS to birth control to heart disease. Vaccine Weekly takes a close look at vaccine-related news and research from around the world. Topics include therapeutic vaccines for AIDS, cancer, and other diseases, efficacy and safety trials, FDA regulation, approvals, prevention, and much more.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Covers the breakthroughs being made in the war against viral pathogens. New and established viral diseases are covered in detail. Topics include drug and vaccine development, drug resistance, gene therapy, clinical trials, virology, viral pathogenesis, biotechnology, epidemiology, animal models, and much more.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00

Since 1994, Women's Health Weekly has been, as the UN organizers of the World Conference on Women said, "...the world's best source on information on women's health." We think you'll agree. If you find staying informed about women's health issues to be a daunting task, we have the solution...Women's Health Weekly. From breast, uterine, and ovarian cancer to obstetrics and gynecological updates, this unique publication keeps you up-to-date.

Single user price: $1,459.00 (1 year), $2,479.00 (2 years), $3,279.00 (3 years).

For multiple users and titles contact Peter Barfoot

One year $1,459.00 Two years $2,479.00 Three years $3,279.00